Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Dan H. Barouch, View ORCID ProfileKathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, Jinyan Liu, Abishek Chandrashekar, Shivani Patel, Mathieu Le Gars, Anne Marit de Groot, Dirk Heerwegh, Frank Struyf, Macaya Douoguih, Johan van Hoof, Hanneke Schuitemaker
doi: https://doi.org/10.1101/2021.07.05.21259918
Dan H. Barouch
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MD PhDKathryn E. Stephenson
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MD MPHJerald Sadoff
2Janssen Vaccines & Prevention, Leiden, The Netherlands
MDJingyou Yu
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
PhDAiquan Chang
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MSMakda Gebre
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MSKatherine McMahan
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
BSJinyan Liu
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
PhDAbishek Chandrashekar
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MSShivani Patel
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
BSMathieu Le Gars
2Janssen Vaccines & Prevention, Leiden, The Netherlands
PhDAnne Marit de Groot
2Janssen Vaccines & Prevention, Leiden, The Netherlands
PhDDirk Heerwegh
3Janssen Research & Development, Beerse, Belgium
PhDFrank Struyf
3Janssen Research & Development, Beerse, Belgium
MDMacaya Douoguih
2Janssen Vaccines & Prevention, Leiden, The Netherlands
MDJohan van Hoof
2Janssen Vaccines & Prevention, Leiden, The Netherlands
MDHanneke Schuitemaker
2Janssen Vaccines & Prevention, Leiden, The Netherlands
PhDData Availability
Requests for access to the study data can be submitted to D.H.B. (dbarouch{at}bidmc.harvard.edu).
Posted July 07, 2021.
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Dan H. Barouch, Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, Jinyan Liu, Abishek Chandrashekar, Shivani Patel, Mathieu Le Gars, Anne Marit de Groot, Dirk Heerwegh, Frank Struyf, Macaya Douoguih, Johan van Hoof, Hanneke Schuitemaker
medRxiv 2021.07.05.21259918; doi: https://doi.org/10.1101/2021.07.05.21259918
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Dan H. Barouch, Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, Jinyan Liu, Abishek Chandrashekar, Shivani Patel, Mathieu Le Gars, Anne Marit de Groot, Dirk Heerwegh, Frank Struyf, Macaya Douoguih, Johan van Hoof, Hanneke Schuitemaker
medRxiv 2021.07.05.21259918; doi: https://doi.org/10.1101/2021.07.05.21259918
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (707)
- Anesthesia (198)
- Cardiovascular Medicine (2905)
- Dermatology (249)
- Emergency Medicine (435)
- Epidemiology (12674)
- Forensic Medicine (10)
- Gastroenterology (822)
- Genetic and Genomic Medicine (4529)
- Geriatric Medicine (411)
- Health Economics (722)
- Health Informatics (2895)
- Health Policy (1065)
- Hematology (382)
- HIV/AIDS (917)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4292)
- Nursing (233)
- Nutrition (630)
- Oncology (2249)
- Ophthalmology (639)
- Orthopedics (257)
- Otolaryngology (324)
- Pain Medicine (274)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1190)
- Primary Care Research (491)
- Public and Global Health (6877)
- Radiology and Imaging (1514)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (481)
- Toxicology (60)
- Transplantation (208)
- Urology (178)